Smruthi Organics Q1 FY27 profit Rs 287.81L vs Rs 109.54L loss last year

Revenue Growth 20pctPat Growth 25pctEbitda Margin ExpansionResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+9.6%Reaction day

₹116.00

prior close

₹119.90

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.1%+9.6% vs market

Pharmaceuticals peers, median of 165sector-0.1%+9.7% vs sector

On the reaction day the stock moved 9.6 pts more than Nifty Microcap 250 and 9.7 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+5.9

10m

+5.1

15m

+1.0

30m

+3.8

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+9.6-0.1+9.6-0.1+9.7

Next day

+7.4-0.2+7.6+0.0+7.4

+8.6+0.1+8.5-0.1+8.7

+11.0+0.3+10.7+0.2+10.9

+7.6+0.4+7.2-0.6+8.2

+5.8+0.5+5.3-1.2+7.0

+9.1+0.3+8.8-2.0+11.1

15d

+23.8+1.9+22.0+0.1+23.7

+36.4+2.2+34.2+1.4+35.1

+30.6-1.2+31.8-2.0+32.7

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 165Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Revenue from operations grew 55 percent YoY to Rs 2,930.22 lakh. Net profit was Rs 287.81 lakh versus a loss of Rs 109.54 lakh in Q1 FY26. EPS was Rs 2.51 against negative Rs 0.96. PBT margin expanded from about 2 percent to nearly 20 percent. Loss-making Formulations division discontinued from May 13, 2026; API is now the only segment. Auditor Gokhale and Sathe gave a clean limited review.

Likely market impact

Strong YoY turnaround from loss to profit on 55 percent revenue growth and margin expansion. Loss-making Formulations division shut.